High caffeine levels associated with weight loss and type 2 diabetes risk: BMJ

Published Date: 17 Mar 2023

UK: A recent study published in BMJ Medicine found that more caffeine in the blood can reduce the risk of type 2 diabetes and obesity. more...

Read Full News

Latest News

Faricimab Reduces Shots, Improves Vision for Retinal Disease

In two studies in retinal disease, faricimab shows improved vision and a reduced injection burden in people who switched from first-generation drugs.

Food Addiction Can Derail Success After Bariatric Surgery

Following bariatric surgery, women with food addiction report a higher intake of ultraprocessed foods, greater anxiety, lower physical activity, and less favorable weight-loss outcomes.

Will Semaglutide Prices Drop After 2026 Patent Expirations?

As patents expire, generic injectable semaglutide could become available at a fraction of current branded prices — around $28-$140 per person-year — in about 162 countries by the end of 2026.

Helping Patients With Diabetes Utilize Technology

Helping patients overcome fear or anxiety around continuous glucose monitoring may be a hurdle.

Novo Sues Lilly, Claiming Misleading Ads in Weight-loss Drug Battle

Novo Nordisk sued rival Eli Lilly in a U.S. federal court on Tuesday, accusing the U.S. drugmaker of false advertising in claiming its weight-loss medicines outperform...

Global Trial to Test Lifestyle Plus Metabolic Tx in Dementia

A $100 million global trial will investigate whether adding a metabolism-targeting therapy to multidomain lifestyle intervention further reduces the risk of cognitive decline in older adults at risk for dementia.

Todays Updates

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

A lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.

Smoldering Myeloma: The Treatment Issue Is Getting Trickier

An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.

Todays Updates

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

A lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.

Smoldering Myeloma: The Treatment Issue Is Getting Trickier

An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.

Latest News

In two studies in retinal disease, faricimab shows improved vision and a reduced injection burden in people who switched from first-generation drugs.

Following bariatric surgery, women with food addiction report a higher intake of ultraprocessed foods, greater anxiety, lower physical activity, and less favorable weight-loss outcomes.

As patents expire, generic injectable semaglutide could become available at a fraction of current branded prices — around $28-$140 per person-year — in about 162 countries by the end of 2026.

Helping patients overcome fear or anxiety around continuous glucose monitoring may be a hurdle.

Novo Nordisk sued rival Eli Lilly in a U.S. federal court on Tuesday, accusing the U.S. drugmaker of false advertising in claiming its weight-loss medicines outperform...

A $100 million global trial will investigate whether adding a metabolism-targeting therapy to multidomain lifestyle intervention further reduces the risk of cognitive decline in older adults at risk for dementia.

News All Time

Managing Diabetes and HIV Together: What to Know

As people with HIV live longer, diabetes is becoming an increasingly important contributor to morbidity and mortality, requiring specialized management approaches.

GLP-1s May Reduce Overdose Risk, Even After Discontinuation

People with a history of alcohol, opioid, or substance overdose who are later started on GLP-1 medications have a significantly lower risk for a repeat overdose.

South Africa's IDexis Appeals Court Ruling Over Compounded Weight-loss Drugs

South African pharmacy group iDexis said on Tuesday it had applied to appeal a court judgment that curbed its production ⁠of compounded weight-loss medicines, disputing...

Study Flags Need to Monitor Frailty Risks With GLP-1 Drugs for Older Adults

Potential signs of frailty in older adults taking Eli Lilly’s GLP-1 obesity drug Zepbound may signal relatively high risks for adverse outcomes, according to a large study...

Merck Gets US FDA Nod for First-in-its-class Oral Cholesterol Drug

The U.S. FDA approved Merck's cholesterol-lowering pill, it said on Thursday, the first in a class of drugs dominated ⁠by injections, which could potentially broaden the use...

Do Infant Food Portion Sizes Matter for Later Overweight?

Larger food portions during complementary feeding are associated with higher odds of overweight in both early and later childhood.

Semaglutide Linked to Rare Brain Illness

In rare cases, semaglutide for obesity is linked to Wernicke encephalopathy, driven by gastrointestinal intolerance, reduced nutritional intake, and rapid weight loss leading to thiamine deficiency.

Screening for Diabetes at Urgent Care Could Save Lives

Millions of Americans have diabetes or prediabetes. Simple screening at urgent care could change their futures.

Women Wait Longer Than Men for a Thyroid Disease Diagnosis

Some symptoms of hypothyroidism and hyperthyroidism overlap with those of other conditions and diseases, which makes differential diagnosis challenging.

Two Dietary Fibers May Cut Crohn’s Risk in Certain Patients

Eating more dietary fibers such as beta-glucan and inulin is linked to a lower risk for Crohn’s disease in first-degree relatives of patients with Crohn’s disease.

Androgen Blood Test May Help Diagnose Endometriosis

Women with endometriosis show a distinct blood androgen profile that distinguishes them from women without the disease, pointing to a possible future noninvasive test.

Ovarian Cancer: Can Repurposed Drugs Work Better Together?

A preclinical study finds that combining atovaquone with platelet-derived growth factor receptor inhibitors reduced ovarian cancer tumoroid viability.

First Non-Hormonal Menopause Drug Approved in Scotland

The Scottish Medicines Consortium has accepted fezolinetant for restricted use within NHS Scotland for menopausal vasomotor symptoms in women who cannot take hormone therapy.

Acromegaly Tied to Elevated Colorectal, Thyroid Cancer Risk

Acromegaly is tied to a higher risk for colorectal cancer and benign colorectal lesions, but the overall long-term cancer risk and cancer-related mortality remain comparable to the general population.

Guidance Aids Adjunctive Incretin Use in Type 1 Diabetes

Positive findings from a phase 2 trial were followed by disappointing news; however, new guidelines aim to help clinicians with off-label prescribing.

Can Sniffing Chocolate Boost Leg Workout Performance?

Sniffing chocolate before performing sets of leg extensions may modulate appetite and increase overall training volume without raising perceived exertion.

Recommended News For You

Having dense breasts is linked to cancer, but advice about breast density can depend on where you live

Can patients receiving immunotherapy for cancer benefit from taking vitamin D supplements?

Scientists are investigating the prevention of recurrent breast cancer, which frequently results in death.

Nodal Response After Chemo Helps Tailor Breast Radiotherapy

No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances

Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer

Recommended Articles For You

Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders 

TAR-200 in Bladder Cancer: Precision Drug Delivery Driving Oncology Advances 

Landmark Medical Oncology Trials Redefining Early Breast Cancer Management 

Immune Surveillance Screening for Early Cancer Risk Detection 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

HER3 Antibody Drug Conjugate Shows Promise in NSCLC

2.

Novel Agent for Chronic GVHD Wins FDA Approval

3.

Cancer mortality continuing to decline, says report

4.

Increased detection of adenomas may reduce colon cancer risk after colonoscopy in FIT-based screening.

5.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

1.

Unleashing the Oncolytic Arsenal: Talimogene Laherparepvec Monotherapy – A Targeted Cancer Immunotherapy Treatment

2.

Unlocking the Potential of Leukemia Treatment: A New Hope for Patients

3.

Unleashing the Inner Predator: Reprogramming Macrophages to Conquer Cancer Immunotherapy

4.

Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook

5.

Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part XI

2.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

3.

A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

4.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

5.

Navigating the Complexities of Ph Negative ALL - Part IX

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot